A61K 47/6909
Micelles formed by phospholipids
Official title: {Micelles formed by phospholipids}
A61K47/6909 (Micelles formed by phospholipids) appears on 44 US grants and 97 published applications in this corpus.
Search patents in A61K- Granted patents
- 44
- Published applications
- 97
- Assignees
- 66
- Inventors
- 221
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 3 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 2 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 3 |
| 2014 | 2 | 4 |
| 2015 | 1 | 5 |
| 2016 | 0 | 4 |
| 2017 | 4 | 5 |
| 2018 | 3 | 2 |
| 2019 | 3 | 10 |
| 2020 | 5 | 12 |
| 2021 | 3 | 4 |
| 2022 | 4 | 9 |
| 2023 | 5 | 13 |
| 2024 | 4 | 11 |
| 2025 | 6 | 6 |
| 2026 | 4 | 3 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for the treatment of neurological diseases and disorders8 Sep 2026US 12,728,128 B2The Regents of the University of California
- EDB-FN as biomarker of cancer and/or brain disease and nanodrug delivery system targeting same2 Jun 2026US 12,642,766 B2Korea Advanced Institute of Science and Technology
- Methods and immunogenic compositions relating to HER2 with selective sequence modifications28 Apr 2026US 12,611,463 B2Wayne State University
- Bottom-up assembly of synthetic extracellular vesicles10 Mar 2026US 12,569,439 B2Max-Planck-Gesellschaft Zur FöRderung Der Wissenschaften E. V.
- MIR-145 micelles for mitigating atherosclerosis30 Dec 2025US 12,508,322 B2University of Southern California
- Affibody micelle drug conjugate13 Aug 2026US 2026/0232835 A1Kowa Company, Ltd.
- Method for delivery of an agent across biological barriers25 Jun 2026US 2026/0174895 A1
- Reversed micelles for delivery of hydrophilic drugs8 Jan 2026US 2026/0007770 A1Consiglio Nazionale Delle Ricerche
- Chemotherapeutic micellular nanoparticles13 Nov 2025US 2025/0345453 A1Peptinovo Biopharma, LLC
- Chemotherapeutic paclitaxel based micellular nanoparticles13 Nov 2025US 2025/0345454 A1Peptinovo Biopharma, LLC
Most cited
By later US patents
- Nanoparticle compositions for sustained therapy7US 10,485,882 B2UTI Limited Partnership · 2019
- Compositions and methods for delivering messenger RNA6US 11,191,849 B2Arbutus Biopharma Corporation · 2021
- Cell transfecting formulations of small interfering RNA related compositions and methods of making and use6US 8,772,255 B2Novartis Vaccines and Diagnostics, Inc. · 2014
- Tuneable delivery of nanoparticle bound active plasmin for the treatment of thrombosis5US 10,583,104 B2Indiana University Research and Technology Corporation · 2020
- Inhibitors of beta integrin-G protein alpha subunit binding interactions5US 8,685,921 B2The Board of Trustees of the University of Illinois · 2014